Merck (MRK) Free Cash Flow (2009 - 2026)

Merck has disclosed Free Cash Flow across 18 years of filings, most recently posting $2.9 billion for Q1 2026.

• In Q1 2026, Free Cash Flow rose 149.74% year-over-year to $2.9 billion; the TTM figure through Mar 2026 stood at $14.1 billion (down 17.16% YoY), while the FY2025 annual figure was $12.4 billion, down 31.7% from the prior year.
• Free Cash Flow improved to $2.9 billion in Q1 2026, from $1.8 billion in the prior quarter.
• Over the last five years, Free Cash Flow for MRK reached as high as $8.5 billion in Q3 2024 and fell as low as -$743.0 million in Q4 2023.
• The 5-year median for Free Cash Flow is $2.9 billion (2026), against an average of $3.4 billion.
• Annual changes were most pronounced in 2022 — Free Cash Flow jumped 2290.51% — and 2023, when it plunged 122.65%.
• A 5-year view of Free Cash Flow shows it stood at $3.3 billion in 2022, then sank by 122.65% to -$743.0 million in 2023, then jumped by 438.22% to $2.5 billion in 2024, then fell by 27.42% to $1.8 billion in 2025, then surged by 60.47% to $2.9 billion in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered $2.9 billion, $1.8 billion, and $6.8 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.